EXO • RESEARCH USE ONLY

Exosomes

Nano-sized extracellular vesicles secreted by mesenchymal stem cells derived from human umbilical cord tissue. They carry signaling molecules including growth factors, cytokines, mRNAs, and miRNAs that modulate cellular processes. Umbilical cord tissue MSC-derived exosomes are associated with an immune-privileged origin, robust paracrine signaling, and regenerative potency, with a cell-free profile that avoids tumorigenicity and immune rejection risks tied to some cell-based approaches. Their profile includes anti-inflammatory, anti-fibrotic, and pro-angiogenic properties.

Nano-EV · RNA-rich

MSC-UCT CARGO

— Extracellular vesicles loaded with growth factors, cytokines, mRNAs, and miRNAs that recapitulate MSC paracrine instruction without delivering intact donor cells.

Anti-fibrotic · pro-angiogenic

FUNCTIONAL PHENOTYPE

— Immune-privileged cord origin paired with anti-inflammatory, anti-fibrotic, and pro-angiogenic signaling relevant to broad regenerative research.

Cell-free alternative

RISK PROFILE

— Discussed as capturing regenerative potency while sidestepping tumorigenicity and immune-rejection concerns tied to some live-cell transplant paradigms.

ROUTES, FORMATS & APPLICATIONS

Routes

IVIMINSQ

Quantities

110 Billion Exosomes

1ml

Potential Applications

Rheumatoid Arthritis
Psoriasis
Multiple Sclerosis (MS)
Systemic Lupus Erythematosus (SLE)
Crohn's Disease
Celiac Disease
Ulcerative Colitis
Type 1 & Type 2 Diabetes
Fibromyalgia
Chronic Inflammation
Chronic Kidney Disease
COPD / Pulmonary Fibrosis
Liver Failure
Skin Rejuvenation / Wrinkles / Aging
Hair Loss (Alopecia)
Intervertebral Disc Degeneration
COVID-19 Pneumonia
Graft-versus-host disease (GvHD)
Erectile Dysfunction
Musculoskeletal Injuries
Systemic inflammation & nerve regeneration
IBD weight-loss protection; elastin synthesis / wound healing

MECHANISM & ORIGIN

MSC-Derived Paracrine Signaling

These exosomes are nano-sized extracellular vesicles from umbilical cord tissue MSCs, carrying growth factors, cytokines, mRNAs, and miRNAs. They reflect immune-privileged origin, robust paracrine signaling, and regenerative potency without the tumorigenicity or immune rejection risks tied to some cell therapies.

Broad molecular cargo

Includes growth factors, cytokines, mRNAs, and miRNAs that modulate recipient cell behavior.

Anti-inflammatory, anti-fibrotic, pro-angiogenic

Documented profile supporting repair and remodeling research pathways.

Cell-free administration

Therapeutic benefits are discussed relative to risks associated with some cell-based therapies, such as tumorigenicity or immune rejection.

Compliance · Exosomes